PediRISE Feasibility

Part of paid clinical trials in San Francisco, California.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT06283251
Status
Recruiting
Apply to this trial

Conditions

  • Disparities
  • Financial Hardship
  • Financial Stress
  • Pediatric Cancer

Eligibility Criteria

Sex
ALL
Age
N/A - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • PediRISE Resource Program — BEHAVIORAL
    A centrally administered, income-poverty targeted intervention that includes twice-monthly direct provision of unrestricted cash transfers along with benefits counseling to mitigate the risk of loss of means-tested benefits. Funds will be dispersed to families via provided debit card or through personal banking, PayPal, or Venmo.

Study Details

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: * PediRISE Program Group * Usual Care Group

Key Dates

Start date
May 15, 2024
Status verified
Feb 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: PediRISE Program Group
    Participants will be randomized in a 1:1 fashion and will be stratified by site. Participant parents will complete: * Baseline survey in-person, by telephone, or virtually. * PediRISE program orientation with study team member, in-person or virtual. * Optional meeting with certified benefits counselor. * Receive fixed funds twice a month for 6 months. * Standard supportive care from social worker and/or resource specialist to identify and discuss available resources. * End of study survey.
  • No Intervention: Usual Care Group
    Participants will be randomized in a 1:1 fashion and will be stratified by site. Participant parents will complete: * Baseline survey in-person, by telephone, or virtually, and orientation with study team member. * Standard supportive care from social worker and/or resource specialist to identify and discuss available resources. * End of study survey.

Primary Outcome Measure

Participant Consent Rate [ Time Frame: 1 Day ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94143
Lena Winestone, MD, MPH
[email protected]
(877) 822-4453
Boston Children's HospitalBostonMassachusetts02215
Kira Bona, MD, MPH
[email protected]
617-632-4688
Kira Bona, MD, MPH (PRINCIPAL_INVESTIGATOR)
Dana Farber Cancer InstituteBostonMassachusetts02215
Kira Bona, MD, MPH
[email protected]
617-632-4688
Kira Bona, MD, MPH (PRINCIPAL_INVESTIGATOR)
Columbia University Medical CenterNew YorkNew York10032
Justine Kahn, MD
[email protected]
(212) 305-9770

Find similar trials in San Francisco, CA

By research site
University of California San Francisco· San Francisco, CABoston Children's Hospital· Boston, MADana Farber Cancer Institute· Boston, MAColumbia University Medical Center· New York, NY

Related Studies